Comparative genomics allowed the identification of drug targets against human fungal pathogens

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Abadio, Ana Karina R ^a,c   Kioshima, Erika S ^a   Teixeira, Marcus M ^a   Martins, Natalia F ^b   Maigret, Bernard ^c   Felipe, Maria Sueli S ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; PROTEIN ERG6; PROTEIN KRE2; PROTEIN RIM8; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

ALKALINITY; AMINO ACID SEQUENCE; ARTICLE; ASPERGILLUS FUMIGATUS; BLASTOMYCES DERMATITIDIS; CANDIDA ALBICANS; CELL SURVIVAL; CELL VIABILITY; CRYPTOCOCCUS NEOFORMANS; DRUG TARGETING; FUNGAL GENOME; GENE FUNCTION; HISTOPLASMA CAPSULATUM; HUMAN; NONHUMAN; PARACOCCIDIOIDES; PARACOCCIDIOIDES BRASILIENSIS; PARACOCCIDIOIDES LUTZII; PH; PHENOTYPE; PHYLOGENY; SEQUENCE ALIGNMENT; SPECIES COMPARISON; CHEMISTRY; CLASSIFICATION; GENETICS; GENOMICS; METHODOLOGY; MOLECULAR GENETICS; PATHOGENICITY; PROTEIN SECONDARY STRUCTURE; SEQUENCE HOMOLOGY;

AJELLOMYCES CAPSULATUS; AJELLOMYCES DERMATITIDIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; COCCIDIOIDES IMMITIS; FILOBASIDIELLA NEOFORMANS; FUNGI; PARACOCCIDIOIDES; PARACOCCIDIOIDES BRASILIENSIS;

AMINO ACID SEQUENCE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUNGAL PROTEINS; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 79251537799     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-75     Document Type: Article

References (61)

1. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001, 33:641-647. 10.1086/322606, 11486286.
2. Alvez F, Figueras C, Roselló E. Emerging invasive fungal infections. An Pediatr (Barc) 2010, 73:52.e1-52.e6.
3. Sable CA, Strohmaier KM, Chodakewitz JA. Advances in antifungal therapy. Annu Rev Med 2008, 59:361-379. 10.1146/annurev.med.59.062906.071602, 17967129.
4. Chapman SW, Sullivan DC, Cleary JD. In search of the holy grail of antifungal therapy. Trans Am Clin Climatol Assoc 2008, 119:197-215. 2394691, 18596853.
5. Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009, 69:361-92. 10.2165/00003495-200969030-00010, 19275278.
6. Brüggemann RJ, Alffenaar JW, Blijlevens NM, Billaud EM, Kosterink JG, Verweij PE, Burger DM. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis 2009, 48:1441-58. 10.1086/598327, 19361301.
7. Fera MT, La Camera E, De Sarro A. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert review of anti-infective therapy 2009, 7:981-998. 10.1586/eri.09.67, 19803707.
8. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 1998, 27:603-18. 10.1086/514704, 9770163.
9. Olson JA, Adler-Moore JP, Jensen GM, Schwartz J, Dignani MC, Proffitt RT. Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products. Antimicrob Agents Chemother 2008, 52:259-268. 10.1128/AAC.00870-07, 2223902, 17967910.
10. Amaral AC, Bocca AL, Ribeiro AM, Nunes J, Peixoto DL, Simioni AR, Primo FL, Lacava ZG, Bentes R, Titze-de-Almeida R, Tedesco AC, Morais PC, Felipe MS. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. J Antimicrob Chemother 2009, 63:526-533. 10.1093/jac/dkn539, 19151037.
11. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010, 9:203-14.
12. Jung K, Park J, Choi J, Park B, Kim S, Ahn K, Choi J, Choi D, Kang S, Lee YH. SNUGB: a versatile genome browser supporting comparative and functional fungal genomics. BMC Genomics 2008, 9:586. 10.1186/1471-2164-9-586, 2649115, 19055845.
13. Janaki C, Joshi RR. Accelerating Comparative Genomics Using Parallel Computing. In Silico Biology 2003, 3:429-440.
14. White TA, Kell DB. Comparative genomic assessment of novel broad-spectrum targets for antibacterial drugs. Comp Funct Genomics 2004, 5:304-327. 10.1002/cfg.411, 2447455, 18629165.
15. Kumar S, Chaudhary K, Foster JM, Novelli JF, Zhang Y, Wang S, Spiro D, Ghedin E, Carlow CKS. Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets. PLoS ONE 2007, 2:e1189. 10.1371/journal.pone.0001189, 2063515, 18000556.
16. Caffrey CR, Rohwer A, Oellien F, Marhöfer RJ, Braschi S, Oliveira G, McKerrow JH, Selzer PM. A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One 2009, 4:e4413. 10.1371/journal.pone.0004413, 2635471, 19198654.
17. Roemer T, Jiang B, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Boone C, Bussey H. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Molecular Microbiology 2003, 50:167-181. 10.1046/j.1365-2958.2003.03697.x, 14507372.
18. Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, Breton A, Linteau1 A, Xin C, Bowman J, Becker J, Jiang B, Roemer T. Essential gene identification and drug target prioritization in Aspergillus fumigates. PLoS pathogens 2007, 3:e24. 10.1371/journal.ppat.0030024, 1817658, 17352532.
19. Buurman ET, Westwater C, Hube B, Brown AJ, Odds FC, Gow NA. Molecular analysis of CaMnt1p, a mannosyltransferase important for adhesion and virulence of Candida albicans. Proc Natl Acad Sci USA 1998, 95:7670-5. 10.1073/pnas.95.13.7670, 22718, 9636208.
20. Jensen-Pergakes KL, Kennedy MA, Lees ND, Barbuch R, Koegel C, Bard M. Sequencing, Disruption, and Characterization of the Candida albicans Sterol Methyltransferase (ERG6) Gene: Drug Susceptibility Studies in erg6 Mutants. Antimicrobial Agents and Chemotherapy 1998, 42:1160-1167. 105764, 9593144.
21. Felipe MS, Andrade RV, Arraes FB, Nicola AM, Maranhão AQ, Torres FA, Silva-Pereira I, Poças-Fonseca MJ, Campos EG, Moraes LM, Andrade PA, Tavares AH, Silva SS, Kyaw CM, Souza DP, Pereira M, Jesuíno RS, Andrade EV, Parente JA, Oliveira GS, Barbosa MS, Martins NF, Fachin AL, Cardoso RS, Passos GA, Almeida NF, Walter ME, Soares CM, Carvalho MJ, Brígido MM, . PbGenome Network Transcriptional profiles of the human pathogenic fungus Paracoccidioides brasiliensis in mycelium and yeast cells. J Biol Chem 2005, 280:24706-24714. 10.1074/jbc.M500625200, 15849188, PbGenome Network.
22. Williams CH, Arscott LD, Muller S, Lennon BW, Ludwig ML, Wang PF, Veine DM, Becker K, Schirmer RH. Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem 2000, 267:6110-6117. 10.1046/j.1432-1327.2000.01702.x, 11012662.
23. Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000, 267:6102-6109. 10.1046/j.1432-1327.2000.01701.x, 11012661.
24. Missall TA, Lodge JK. Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans. Eukaryot Cell 2005, 4:487-9. 10.1128/EC.4.2.487-489.2005, 549343, 15701811.
25. Krnajski Z, Gilberger TW, Walter RD, Cowman AF, Muller S. Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages. J Biol Chem 2002, 277:25970-25975. 10.1074/jbc.M203539200, 12004069.
26. Uziel O, Borovok I, Schreiber R, Cohen G, Aharonowitz Y. Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress. J Bacteriol 2004, 186:326-334. 10.1128/JB.186.2.326-334.2004, 305758, 14702300.
27. Machado AK, Morgan BA, Merrill GF. Thioredoxin reductase-dependent inhibition of MCB cell cycle box activity in Saccharomyces cerevisiae. J Biol Chem 1997, 272:17045-17054. 10.1074/jbc.272.27.17045, 9202020.
28. Pearson GD, Merrill GF. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J Biol Chem 1998, 273:5431-5434. 10.1074/jbc.273.10.5431, 9488661.
29. Peñalva MA, Arst HN. Regulation of gene expression by ambient pH in filamentous fungi and yeasts. Microbiology and Molecular Biology Reviews 2002, 66:426-446. 10.1128/MMBR.66.3.426-446.2002, 120796, 12208998.
30. Herranz S, Rodríguez JM, Bussink HJ, Sánchez-Ferrero JC, Arst HN, Peñalva MA, Vincent O. Arrestin-related proteins mediate pH signaling in fungi. Proc Natl Acad Sci USA 2005, 102:12141-12146. 10.1073/pnas.0504776102, 1189327, 16099830.
31. Davis D, Edwards JE, Mitchell AP, Ibrahim AS. Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun 2000, 68:5953-5959. 10.1128/IAI.68.10.5953-5959.2000, 101559, 10992507.
32. Lussier M, Sdicu AM, Ketela T, Bussey H. Localization and targeting of the Saccharomyces cerevisiae Kre2p/Mnt1p alpha 1,2-mannosyltransferase to a medial-Golgi compartment. J Cell Biol 1995, 131:913-927. 10.1083/jcb.131.4.913, 2200012, 7490293.
33. Häusler A, Ballou L, Ballou CE, Robbins PW. Yeast glycoprotein biosynthesis: MNT1 encodes an alpha-1,2-mannosyltransferase involved in O-glycosylation. Proc Natl Acad Sci USA 1992, 89:6846-6850. 10.1073/pnas.89.15.6846, 49601, 1495972.
34. Hill K, Boone C, Goebl M, Puccia R, Sdicu AM, Bussey H. Yeast KRE2 Defines a New Gene Family Encoding Probable Secretory Proteins, and Is Required for the Correct N-Glycosylation of Proteins. Genetics 1992, 130:273-283. 1204848, 1541391.
35. Lussier M, Sdicu AM, Bussereau F, Jacquet M, Bussey H. The Ktr1p, Ktr3p, and Kre2p/Mnt1p mannosyltransferases participate in the elaboration of yeast O- and N-linked carbohydrate chains. The Journal of Biological Chemistry 1997, 272:15527-15531. 10.1074/jbc.272.24.15527, 9182588.
36. Wagener J, Echtenacher B, Rohde M, Kotz A, Krappmann S, Heesemann J, Ebel F. The putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence. Eukaryot Cell 2008, 7:1661-1673. 10.1128/EC.00221-08, 2568062, 18708564.
37. Munro CA, Bates S, Buurman ET, Hughes HB, Maccallum DM, Bertram G, Atrih A, Ferguson MA, Bain JM, Brand A, Hamilton S, Westwater C, Thomson LM, Brown AJ, Odds FC, Gow NA. Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem 2005, 280:1051-1060. 10.1074/jbc.M411413200, 15519997.
38. McCammon MT, Hartmann M, Bottema CD, Parks LW. Sterol methylation in Saccharomyces cerevisiae. Journal of bacteriology 1984, 157:475-483. 215272, 6363386.
39. Natter K, Leitner P, Faschinger A, Wolinski H, McCraith S, Fields S, Kohlwein SD. The spatial organization of lipid synthesis in the yeast Saccharomyces cerevisiae derived from large scale green fluorescent protein tagging and high resolution microscopy. Mol Cell Proteomics 2005, 4:662-672. 10.1074/mcp.M400123-MCP200, 15716577.
40. Nes WD, Janssen GG, Bergenstrahle A. Structural requirements for transformation of substrates by the (S)-adenosyl-L-methionine:delta 24(25)-sterol methyl transferase. J Biol Chem 1991, 266:15202-15212.
41. Gaber RF, Copple DM, Kennedy BK, Vidal M, Bard M. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Molecular and Cellular Biology 1989, 9:3447-3456. 362391, 2677674.
42. Zweytick D, Leitner E, Kohlwein SD, Yu C, Rothblatt J, Daum G. Contribution of Are1p and Are2p to steryl ester synthesis in the yeast Saccharomyces cerevisiae. Eur J Biochem 2000, 267:1075-1082. 10.1046/j.1432-1327.2000.01103.x, 10672016.
43. Young LY, Hull CM, Heitman J. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 2003, 47:2717-2724. 10.1128/AAC.47.9.2717-2724.2003, 182600, 12936965.
44. Veine DM, Mulrooney SB, Wang PF, Williams CH. Formation and properties of mixed disulfides between thioredoxin reductase from Escherichia coli and thioredoxin: evidence that cysteine-138 functions to initiate dithiol-disulfide interchange and to accept the reducing equivalent from reduced flavin. Protein Sci 1998, 7:1441-50. 10.1002/pro.5560070621, 2144040, 9655349.
45. Zhang Z, Bao R, Zhang Y, Yu J, Zhou CZ, Chen Y. Crystal structure of Saccharomyces cerevisiae cytoplasmic thioredoxin reductase Trr1 reveals the structural basis for species-specific recognition of thioredoxin. Biochim Biophys Acta 2009, 1794:124-128.
46. Thomson LM, Bates S, Yamazaki S, Arisawa M, Aoki Y, Gow NA. Functional characterization of the Candida albicans MNT1 mannosyltransferase expressed heterologously in Pichia pastoris. J Biol Chem 2000, 275:18933-8. 10.1074/jbc.M909699199, 10766761.
47. Lobsanov YD, Romero PA, Sleno B, Yu B, Yip P, Herscovics A, Howell PL. Structure of Kre2p/Mnt1p: a yeast alpha1,2-mannosyltransferase involved in mannoprotein biosynthesis. J Biol Chem 2004, 279:17921-17931. 10.1074/jbc.M312720200, 14752117.
48. Nes WD, McCourt BS, Zhou W, Ma J, Marshall JA, Peek LA, Brennan M. Overexpression, purification, and stereochemical studies of the recombinant (S)-adenosyl-L-methionine: D24(25)- to D24(28)-sterol methyl transferase enzyme from Saccharomyces cerevisiae. Arch Biochem Biophys 1998, 353:297-311. 10.1006/abbi.1998.0665, 9606964.
49. Nes WD, Marshall JA, Jia Z, Jaradat TT, Song Z, Jayasimha P. Active site mapping and substrate channeling in the sterol methyltransferase pathway. J Biol Chem 2002, 277:42549-56. 10.1074/jbc.M204223200, 12196515.
50. Nes WD, McCourt BS, Marshall JA, Ma J, Dennis AL, Lopez M, Li H, He L. Site-directed mutagenesis of the sterol methyl transferase active site from Saccharomyces cerevisiae results in formation of novel 24-ethyl sterols. J Org Chem 1999, 64:1535-1542. 10.1021/jo9819943, 11674216.
51. Nes WD. Enzyme redesign and interactions of substrate analogues with sterol methyltransferase to understand phytosterol diversity, reaction mechanism and the nature of the active site. Biochem Soc Trans 2005, 33:1189-1196. 10.1042/BST20051189, 16246079.
52. Ganapathy K, Jones CW, Stephens CM, Vatsyayan R, Marshall JA, Nes WD. Molecular probing of the Saccharomyces cerevisiae sterol 24-C methyltransferase reveals multiple amino acid residues involved with C2-transfer activity. Biochim Biophys Acta 2008, 1781:344-351.
53. Teixeira MM, Theodoro RC, de Carvalho MJ, Fernandes L, Paes HC, Hahn RC, Mendoza L, Bagagli E, San-Blas G, Felipe MS. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol 2009, 52:273-83. 10.1016/j.ympev.2009.04.005, 19376249.
54. Cavasotto CN, Phatak SS. Homology modeling in drug discovery: current trends and applications. Drug Discov Today 2009, 14:676-683. 10.1016/j.drudis.2009.04.006, 19422931.
55. Marshall GR. Introduction to cheminformatics in drug discovery - A personal view. Chemioinformatics in drug discovery 2004, 23. Oprea, Weinhein: WILEY-VHC, Tudor I, ISBN: 3-527-30753-2.
56. Dai S, Saarinen M, Ramaswamy S, Meyer Y, Jacquot JP, Eklund H. Crystal Structure of Arabidopsis thaliana NADPH Dependent Thioredoxin Reductase at 2.5 Å Resolution. J Mol Biol 1996, 264:1044-1057. 10.1006/jmbi.1996.0695, 9000629.
57. Oliveira MA, Discola KF, Alves SV, Medrano FJ, Guimarães BG, Netto LES. Insights into the specificity of thioredoxin reductase-thioredoxin interactions. A structural and functional investigation of the yeast thioredoxin system. Biochemistry 2010, 49:3317-3326. 10.1021/bi901962p, 20235561.
58. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-80. 10.1093/nar/22.22.4673, 308517, 7984417.
59. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999, 41:95-98.
60. Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19:1572-4. 10.1093/bioinformatics/btg180, 12912839.
61. Jones DT, Taylor WR, Thornton JM. The Rapid Generation of Mutation Data Matrices from Protein Sequences. Comput Applic Biosci 1992, 8:275-282.